State Street’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.3M | Sell |
2,830,074
-257,021
| -8% | -$4.11M | ﹤0.01% | 1728 |
|
2025
Q1 | $52.8M | Buy |
3,087,095
+389,573
| +14% | +$6.66M | ﹤0.01% | 1597 |
|
2024
Q4 | $66.8M | Sell |
2,697,522
-324,820
| -11% | -$8.05M | ﹤0.01% | 1573 |
|
2024
Q3 | $86.2M | Buy |
3,022,342
+303,386
| +11% | +$8.65M | ﹤0.01% | 1410 |
|
2024
Q2 | $71.8M | Sell |
2,718,956
-922,951
| -25% | -$24.4M | ﹤0.01% | 1461 |
|
2024
Q1 | $118M | Buy |
3,641,907
+425,531
| +13% | +$13.7M | 0.01% | 1205 |
|
2023
Q4 | $136M | Sell |
3,216,376
-252,241
| -7% | -$10.6M | 0.01% | 1094 |
|
2023
Q3 | $133M | Buy |
3,468,617
+234,448
| +7% | +$9M | 0.01% | 995 |
|
2023
Q2 | $61.4M | Sell |
3,234,169
-733,436
| -18% | -$13.9M | ﹤0.01% | 1534 |
|
2023
Q1 | $61.5M | Buy |
3,967,605
+854,662
| +27% | +$13.3M | ﹤0.01% | 1506 |
|
2022
Q4 | $55.3M | Buy |
3,112,943
+2,234,342
| +254% | +$39.7M | ﹤0.01% | 1558 |
|
2022
Q3 | $4.9M | Sell |
878,601
-14,079
| -2% | -$78.6K | ﹤0.01% | 3071 |
|
2022
Q2 | $3.48M | Buy |
892,680
+56,938
| +7% | +$222K | ﹤0.01% | 3272 |
|
2022
Q1 | $4.61M | Sell |
835,742
-1,947,052
| -70% | -$10.7M | ﹤0.01% | 3222 |
|
2021
Q4 | $23.7M | Sell |
2,782,794
-1,329,000
| -32% | -$11.3M | ﹤0.01% | 2347 |
|
2021
Q3 | $35.7M | Sell |
4,111,794
-278,843
| -6% | -$2.42M | ﹤0.01% | 2045 |
|
2021
Q2 | $46.4M | Buy |
4,390,637
+774,877
| +21% | +$8.19M | ﹤0.01% | 1901 |
|
2021
Q1 | $58M | Buy |
3,615,760
+1,746,740
| +93% | +$28M | ﹤0.01% | 1631 |
|
2020
Q4 | $86.3M | Buy |
1,869,020
+717,555
| +62% | +$33.1M | 0.01% | 1259 |
|
2020
Q3 | $40.5M | Buy |
1,151,465
+819,890
| +247% | +$28.9M | ﹤0.01% | 1606 |
|
2020
Q2 | $8.07M | Buy |
+331,575
| New | +$8.07M | ﹤0.01% | 2537 |
|